Relafen 750, structurally known as its salt form, offers a distinct physiological pathway of action. From a drug standpoint , it functions primarily as a non-copyrightal medication, inhibiting COX enzymes – particularly COX-1 and COX-2 – to reduce inflammation and discomfort. The subsequent decrease in inflammatory mediator production impacts a